VC Mapping Home
Industries
Stages
Countries
Cities
Find investors on Gilion
Industries
AppsAIBiotechFintechSoftwareSaaSMartechLegaltechE-commerce
Countries
DenmarkFinlandFranceGermanySwedenUnited KingdomUnited States
Cities
AmsterdamBerlinBostonCopenhagenLondonLos AngelesMiamiMunichNew YorkParisSan FransiscoSeattleSilicon ValleyStockholm
Investment Stages
Early-StagePre-SeedSeedSeries ASeries B
>
VC Firms
>
Shangbay Capital

Shangbay Capital

Last updated:

April 25, 2025

2015

Founded

25

Investments

United States

Offices

Venture Fund

Investor Type

About the firm

ShangBay Capital is a venture capital firm established in 2015 and based in Palo Alto, California. The firm specializes in early-stage investments within the medical device, biotechnology, and healthcare technology sectors. With a combined experience of over 100 years, ShangBay Capital's leadership team has cultivated strong relationships with strategic partners and innovators in disruptive technologies.

Their investment philosophy focuses on supporting founders who address significant unmet clinical needs with novel solutions, aiming to generate favorable returns by satisfying large market demands.

Investment Focus

No items found.

Investment Stage

Pre-Seed
Seed
Series A

HQ Locations

United States
Palo Alto

Portfolio Companies

Fluid Biomed, Venova Medical, Laplace Interventional, Luminopia, Solenic Medical, Noah Medical, Flare Therapeutics, Alleviant Medical, SetPoint Medical, Contraline

Gepgraphic Focus

United States, Europe

Key Differentiators

Deep industry experience with over 100 years combined leadership, Strong ties to strategics and innovators in disruptive technologies, Focus on addressing high, unmet clinical needs with novel ideas

Thypical Investment Size

Investments range from $5 million to $150 million, depending on the stage and needs of the portfolio company.

Total Funds Raised

Over $2 billion under management.

Visit Website

Website

Palo Alto

Pre-Seed

Seed

Series A

United States